Two Seas Capital LP

Position in QURE — uniQure N.V.

CIK 1823138 RYE, NY

Position in QURE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$21,255,000

New position

Shares Held

1,300,000

first reported quarter

Ownership

2.06%

of shares outstanding

% of Portfolio

0.99%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Two Seas Capital LP holds $583,657,196 across 5 Biotechnology names. QURE ranks #5 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	9,328,291	$258,393,660
2	NKTR	Nektar Therapeutics	1,959,178	$140,962,857
3	ABUS	Arbutus Biopharma Corp	18,557,543	$83,508,943
4	IMVT	Immunovant, Inc.	3,201,962	$79,536,736
5	QURE	uniQure N.V. This page	1,300,000	$21,255,000

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$21,255,000	1,300,000	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.